| pubmed-article:15390288 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15390288 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15390288 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:15390288 | lifeskim:mentions | umls-concept:C0006118 | lld:lifeskim |
| pubmed-article:15390288 | lifeskim:mentions | umls-concept:C1861172 | lld:lifeskim |
| pubmed-article:15390288 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
| pubmed-article:15390288 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15390288 | pubmed:dateCreated | 2004-10-7 | lld:pubmed |
| pubmed-article:15390288 | pubmed:abstractText | Venous thromboembolism (VTE) is a common event in adults with malignant brain tumors approaching 24% throughout the course of the disease. The high morbidity and mortality of this complication yielded several protocols for prevention of the disease in adults undergoing neurosurgery for brain tumors and possible primary prevention afterwards. We investigated the incidence and complications of VTE in pediatric neuro-oncology patients. | lld:pubmed |
| pubmed-article:15390288 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15390288 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15390288 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15390288 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15390288 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:15390288 | pubmed:issn | 1545-5009 | lld:pubmed |
| pubmed-article:15390288 | pubmed:author | pubmed-author:RechaviGideon... | lld:pubmed |
| pubmed-article:15390288 | pubmed:author | pubmed-author:TorenAmosA | lld:pubmed |
| pubmed-article:15390288 | pubmed:author | pubmed-author:Beni-AdaniLia... | lld:pubmed |
| pubmed-article:15390288 | pubmed:author | pubmed-author:ConstantiniSh... | lld:pubmed |
| pubmed-article:15390288 | pubmed:author | pubmed-author:FeldmanZeevZ | lld:pubmed |
| pubmed-article:15390288 | pubmed:author | pubmed-author:BursteinYoavY | lld:pubmed |
| pubmed-article:15390288 | pubmed:author | pubmed-author:PessachItaiI | lld:pubmed |
| pubmed-article:15390288 | pubmed:author | pubmed-author:TaboriUriU | lld:pubmed |
| pubmed-article:15390288 | pubmed:author | pubmed-author:DvirRinaR | lld:pubmed |
| pubmed-article:15390288 | pubmed:copyrightInfo | (c) 2004 Wiley-Liss, Inc. | lld:pubmed |
| pubmed-article:15390288 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15390288 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:15390288 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15390288 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15390288 | pubmed:pagination | 633-6 | lld:pubmed |
| pubmed-article:15390288 | pubmed:dateRevised | 2009-1-12 | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:meshHeading | pubmed-meshheading:15390288... | lld:pubmed |
| pubmed-article:15390288 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15390288 | pubmed:articleTitle | Risk of venous thromboembolism in pediatric patients with brain tumors. | lld:pubmed |
| pubmed-article:15390288 | pubmed:affiliation | Pediatric Hemato-oncology, Danna Childrens Hospital, Tel Aviv, Israel. uri.tabori@sickkids.ca | lld:pubmed |
| pubmed-article:15390288 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15390288 | lld:pubmed |
